{"disease":{"id":"esophageal-neoplasms-malignancy-unspecified","name":"esophageal neoplasms malignancy unspecified"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03108885","title":"Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence","phase":"","overall_status":"TERMINATED","enrollment_count":11,"lead_sponsor_name":"Mayo Clinic","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}